SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q4 2022
Institutional positions in SAB Biotherapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- 0 vs. Q3 2022
- Shares held
- 4.09M
- +807.8K (+24.6%) vs. Q3 2022
- Total value
- $2.42M
- +$113.1K (+4.9%) vs. Q3 2022
- New holders
- 8
- 9 more added
- Sold out
- 8
- 9 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rockefeller Capital Management L.P. | 1,500 | $0 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 145 | $0 | 0.00% | +145 | New |
| Bank of America Corp | 38 | $22 | 0.00% | −432−91.9% | Reduced |
| Wells Fargo & Company | 185 | $109 | 0.00% | +5+2.8% | Added |
| Money Concepts Capital Corp | 250 | $147 | 0.00% | +250 | New |
| JPMorgan Chase & Co | 881 | $1.00K | 0.00% | −1,744−66.4% | Reduced |
| Royal Bank of Canada | 4,820 | $3.00K | 0.00% | −299−5.8% | Reduced |
| UBS Group AG | 6,927 | $4.09K | 0.00% | +5,423+360.6% | Added |
| 1st Source Bank | 10,000 | $5.90K | 0.00% | 00.0% | Unchanged |
| Baird Financial Group, Inc. | 10,000 | $6.00K | 0.00% | +10,000 | New |
| Kestra Advisory Services, LLC | 11,000 | $6.49K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 11,441 | $6.75K | 0.00% | +11,441 | New |
| Tower Research Capital LLC (TRC) | 11,411 | $7.00K | 0.00% | −2,231−16.4% | Reduced |
| Nadler Financial Group, Inc. | 13,750 | $8.11K | 0.00% | +13,750 | New |
| Elgethun Capital Management | 14,796 | $9.17K | 0.00% | +1,500+11.3% | Added |
| Charles Schwab Investment Management Inc | 16,238 | $9.58K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 17,207 | $10.2K | 0.00% | −7,864−31.4% | Reduced |
| AE Wealth Management LLC | 18,700 | $11.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 19,096 | $11.3K | 0.00% | +16,883+762.9% | Added |
| Brookstone Capital Management | 21,755 | $13.3K | 0.00% | +5,290+32.1% | Added |
| LGL Partners, LLC | 23,000 | $13.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 44,476 | $26.2K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 48,518 | $28.6K | 0.00% | +1,000+2.1% | Added |
| Silver Oak Securities, Inc | 51,941 | $31.0K | 0.01% | +51,941 | New |
| Mariner, LLC | 69,000 | $41.0K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 75,970 | $44.0K | 0.00% | +75,970 | New |
| State Street Corp | 81,241 | $47.9K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 84,000 | $49.6K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 108,153 | $63.8K | 0.00% | −17,569−14.0% | Reduced |
| Citadel Advisors LLC | 109,215 | $64.4K | 0.00% | +69,053+171.9% | Added |
| Meteora Capital, LLC | 134,524 | $79.4K | 0.02% | −115,001−46.1% | Reduced |
| Institutional & Family Asset Management, LLC | 149,774 | $88.4K | 0.01% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 236,621 | $140.0K | 0.00% | −38,379−14.0% | Reduced |
| Geode Capital Management, LLC | 300,529 | $177.0K | 0.00% | −16,134−5.1% | Reduced |
| Warberg Asset Management LLC | 370,370 | $218.5K | 0.07% | +370,370 | New |
| Veritable, L.P. | 506,513 | $298.8K | 0.01% | +462,962+1,063.0% | Added |
| Vanguard Group Inc | 701,584 | $413.9K | 0.00% | +581+0.1% | Added |
| First PREMIER Bank | 807,535 | $476.0K | 0.14% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −38,547−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −23,954−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −12,618−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −9,000−100.0% | Sold out |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −3,926−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −494−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −127−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −403−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |
| Spectrum Management Group, LLC | – | – | – | – | Not filed |